Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
JCI Insight|October 5, 2018
SYK inhibitor entospletinib prevents ocular and skin GVHD in miceJonathan C Poe, Wei Jia, Julie A Di Paolo, et al.
Blood Advances|January 24, 2025
Cutaneous dysbiosis characterizes the post-allogeneic hematopoietic stem cell transplantation periodAdela R Cardones, Akintunde Emiola, Russell P Hall, et al.
International Journal of Dermatology|May 19, 2023
Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and managementRohan Mital, Tracey S Otto, Andrei Savu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 29, 2024
S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and VenereologyFrédéric Caux, Aikaterini Patsatsi, Meropi Karakioulaki, et al.
Transplantation and Cellular Therapy|December 28, 2022
A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host DiseaseChenyu Lin, Rachel A DiCioccio, Tarek Haykal, et al.
Journal of the American Academy of Dermatology|March 11, 2020
Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adultsLucia Seminario-Vidal, Daniela Kroshinsky, Stephen J Malachowski, et al.
The Journal of Investigative Dermatology|May 15, 2018
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United StatesRobert G Micheletti, Zelma Chiesa-Fuxench, Megan H Noe, et al.
Pageof 5